Report for Alexandre J

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (2)

Title : Disproportionality analysis in VigiBase as a drug repositioning method for the discovery of potentially useful drugs in Alzheimer's disease - Chretien_2021_Br.J.Clin.Pharmacol_87_2830
Author(s) : Chretien B , Jourdan JP , Davis A , Fedrizzi S , Bureau R , Sassier M , Rochais C , Alexandre J , Lelong-Boulouard V , Dolladille C , Dallemagne P
Ref : British Journal of Clinical Pharmacology , 87 :2830 , 2021
Abstract : Chretien_2021_Br.J.Clin.Pharmacol_87_2830
ESTHER : Chretien_2021_Br.J.Clin.Pharmacol_87_2830
PubMedSearch : Chretien_2021_Br.J.Clin.Pharmacol_87_2830
PubMedID: 33274491

Title : Serum soluble CD26\/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibody - Kaneko_2021_Biomark.Res_9_21
Author(s) : Kaneko Y , Hatano R , Hirota N , Isambert N , Trillet-Lenoir V , You B , Alexandre J , Zalcman G , Valleix F , Podoll T , Umezawa Y , Takao S , Iwata S , Hosono O , Taguchi T , Yamada T , Dang NH , Ohnuma K , Angevin E , Morimoto C
Ref : Biomark Res , 9 :21 , 2021
Abstract : Kaneko_2021_Biomark.Res_9_21
ESTHER : Kaneko_2021_Biomark.Res_9_21
PubMedSearch : Kaneko_2021_Biomark.Res_9_21
PubMedID: 33757558